Nimotop en es it fr

Nimotop Brand names, Nimotop Analogs

Nimotop Brand Names Mixture

  • No information avaliable

Nimotop Chemical_Formula


Nimotop RX_link

Nimotop fda sheet

Nimotop FDA

Nimotop msds (material safety sheet)

Nimotop Synthesis Reference

No information avaliable

Nimotop Molecular Weight

418.44 g/mol

Nimotop Melting Point

No information avaliable

Nimotop H2O Solubility

No information avaliable

Nimotop State


Nimotop LogP


Nimotop Dosage Forms


Nimotop Indication

For the treatment of subarachnoid bleeding.

Nimotop Pharmacology

Nimodipine belongs to the class of pharmacological agents known as calcium channel blockers. Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured congenital aneurysms who are in good neurological condition post-ictus (e.g., Hunt and Hess Grades I-III). The contractile processes of smooth muscle cells are dependent upon calcium ions, which enter these cells during depolarization as slow ionic transmembrane currents. Nimodipine inhibits calcium ion transfer into these cells and thus inhibits contractions of vascular smooth muscle. In animal experiments, nimodipine had a greater effect on cerebral arteries than on arteries elsewhere in the body perhaps because it is highly lipophilic, allowing it to cross the blood brain barrier.

Nimotop Absorption

No information avaliable

Nimotop side effects and Toxicity

No information avaliable

Nimotop Patient Information

No information avaliable

Nimotop Organisms Affected

Humans and other mammals